跳至主要内容
临床试验/NCT02798965
NCT02798965已完成不适用

Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2010年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
1
主要终点
prevalence of circulating parvovirus genome

研究概览

简要总结

Lymphocytic thyroiditis is the most common autoimmune disease, usually affecting young women. Although the aetiology and pathogenesis remain obscure, the most widely accepted hypothesis is an interaction between a genetic predisposition and an environmental trigger factor such as viral infection. Parvovirus infections have been proposed as trigger factors for Hashimoto's thyroiditis and Graves' disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Graves' disease :patients treated for Graves' disease, the diagnosis date less than 4 months
  • Control : patients cared for nodules or goiter

排除标准

  • Patients undergoing immunosuppressive therapy including corticosteroids

研究组 & 干预措施

Control

Other

patients with goiter or nodule

干预措施: serodiagnosis (Biological)

Graves' disease

Experimental

patients with Graves' disease

干预措施: serodiagnosis (Biological)

结局指标

主要结局

prevalence of circulating parvovirus genome

时间窗: Day 0

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验